Immunotherapy in head and neck cancer: Harnessing profit on a system disruption

C Rancoule, A Vallard, S Espenel, JB Guy, Y Xia… - Oral Oncology, 2016 - Elsevier
Immune system deregulation and evasion play a key role in cancers' evolution and
progression, including squamous cell carcinoma of the head and neck (SCCHN) …
被引用次数：9 相关文章

Immunotherapy in head and neck cancer: Harnessing profit on a system disruption

C Rancoule, A Vallard, S Espenel, JB Guy, Y Xia… - Oral Oncology, 2016 - infona.pl
Immune system deregulation and evasion play a key role in cancers' evolution and
progression, including squamous cell carcinoma of the head and neck (SCCHN) …

Immunotherapy in head and neck cancer: Harnessing profit on a system disruption.

C Rancoule, A Vallard, S Espenel, JB Guy, Y Xia… - Oral …, 2016 - europepmc.org
Immune system deregulation and evasion play a key role in cancers' evolution and
progression, including squamous cell carcinoma of the head and neck (SCCHN) …

Immunotherapy in head and neck cancer: Harnessing profit on a system disruption

C Rancoule, A Vallard, S Espenel, JB Guy, Y Xia, M El… - Oral Oncology, 2016 - hal.science
Immune system deregulation and evasion play a key role in cancers' evolution and
progression, including squamous cell carcinoma of the head and neck (SCCHN) …

Immunotherapy in head and neck cancer: Harnessing profit on a system disruption

C Rancoule, A Vallard, S Espenel, JB Guy… - Oral …, 2016 - pubmed.ncbi.nlm.nih.gov
Immune system deregulation and evasion play a key role in cancers' evolution and
progression, including squamous cell carcinoma of the head and neck (SCCHN) …